Merck's oral PCSK9 inhibitor shows 59% LDL-C reduction in HeFH trial

2 hours ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Merck's oral PCSK9 inhibitor shows 59% LDL-C reduction in HeFH trial

Related

RadNet earnings missed by $0.03, revenue topped estimates

RadNet earnings missed by $0.03, revenue topped estimates

39 minutes ago 0
UK firms plan 3% pay rises in coming year, see AI hit to jobs, survey shows

UK firms plan 3% pay rises in coming year, see AI hit to job...

39 minutes ago 0
Japan PM Takaichi signals watering down of fiscal consolidation target

Japan PM Takaichi signals watering down of fiscal consolidat...

39 minutes ago 0

Trending

1. i love la show
2. jabari walker
3. is steph curry playing tonight
4. justin hartley
5. jim harbaugh
6. calvin austin
7. justin herbert girlfriend
8. carrie underwood
9. portland vs san diego fc
10. timberwolves vs kings

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

9 months ago 596
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

7 months ago 450
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

8 months ago 300
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

10 months ago 286
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

8 months ago 266
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved